Trials / Completed
CompletedNCT04229888
Meibomian Gland Dysfunction Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LipiFlow | Medical device that applies a combination of heat and pressure to the inner eyelid to remove gland obstructions and stagnant gland content |
| DEVICE | Light Based (Sham) Treatment | A light based (sham) treatment will be used to compare effectiveness to the LipiFlow treatment. |
Timeline
- Start date
- 2020-02-26
- Primary completion
- 2021-03-25
- Completion
- 2021-03-25
- First posted
- 2020-01-18
- Last updated
- 2022-03-29
- Results posted
- 2022-03-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04229888. Inclusion in this directory is not an endorsement.